Studies of oxidant-induced changes in albumin transport function with a fluorescent probe K-35. Effect of hypochlorite

Bulletin of Experimental Biology and Medicine

Volumn 152, Issue 6, 2012, Pages 712-716

  Azizova, O A ^a   Aseychev, A V ^a   Beckman, E M ^a   Moskvina, S N ^a   Skotnikova, O I ^a   Smolina, N V ^a   Gryzunov, Yu A ^a   Dobretsov, G E ^a  

^a Institute of Physico Chemical Medicine   (Russian Federation)

Author keywords

Albumin; Albumin effective concentration; Fluorescent probe; Hypochlorite; K 35

Indexed keywords

5,6,7,8 TETRAHYDRO 1,2,11 TRIMETHOXY 6 METHYLDIBENZ[C,E]AZOCINE; ALBUMIN; CARBONYL DERIVATIVE; DITYROSINE; FLUORESCENT DYE; HYPOCHLORITE; OXIDIZING AGENT; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; DYNAMICS; HUMAN; OPTICAL DENSITY; OXIDATION; OXIDATIVE STRESS; PLASMA; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN MODIFICATION; PROTEIN TRANSPORT; SERUM;

EID: 85027924189     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-012-1613-z     Document Type: Article

References (15)

1. Blood Serum Albumin in Clinical Medicine, Eds. Yu. A. Gryzunov and G. E. Dobretsov [in Russian], Moscow (1994).
2. Yu. A. Vladimirov, O. A. Azizova A. I. Deev, et al., Itogi Nauki Tekhniki VINITI AN SSSR. Biofizika, 29, 1-252 (1991).
3. G. E. Dobretsov, Yu. A. Gryzunov, N. V. Smolina, et al., Efferentnaya Fiziko-Khimicheskaya Meditsina, No. 1, 16-26 (2009).
4. E. E. Dubinina, S. V. Gavrovskaya, E. V. Kuz'mich, et al., Biokhimiya, 67, No. 3, 413-421 (2002).
5. Yu. I. Miller and G. E. Dobretsov, Blood Serum Albumin in Clinical Medicine, Eds. Yu. A. Gryzunov and G. E. Dobretsov [in Russian], Moscow (1998), pp. 161-163.
6. M. Anraku, K. Yamasaki, T. Maruyama, et al., Pharm. Res., 18, No. 5, 632-639 (2001).
7. G. Candiano, A. Petretto, M. Bruschi, et al., J. Proteomics, 73, No. 2, 188-195 (2009).
8. H. A. Headlam and M. J. Davies, Free Radic. Biol. Med., 36, No. 9, 1175-1184 (2004).
9. A. J. Kettle and C. C. Winterbourn, Methods Enzymol., 233, 502-512 (1994).
10. N. Khansari, Y. Shakiba, and M. Mahmoudi, Recent Pat. Inflamm. Allergy Drug Discov., 3, No. 1, 73-80 (2009).
11. S. J. Klebanoff, J. Leukoc. Biol., 77, No. 5, 598-625 (2005).
12. R. Levine, J. A. Williams, E. R. Stadman, and E. Shacter, Methods Enzymol., 233, 346-357 (1994).
13. T. J. Mocatta, A. P. Pilbrow, V. A. Cameron, et al., J. Am. Coll. Cardiol., 49, No. 20, 1993-2000 (2007).
14. K. Oettl and R. E. Stauber, Br. J. Pharmacol., 151, No. 5, 580-590 (2007).
15. D. I. Pattison, C. L. Hawkins, and M. J. Davies, Chem. Res. Toxicol., 22, No. 5, 807-817 (2009).